AzTrials
AzTrials

PainPhase 3PVBS-USguidedNCT02865226

Comparison of the Clinical Efficacy of 2 Paravertebral Block Strategies in Thoracic Surgery by Thoracotomy: by the Anesthetist (Paravertebral Block Guided by Ultrasound) and by the Thoracic Surgeon (Paravertebral Block Visual)

A Phase 3 study testing paravertebral block by the anesthetist before incision (paravertebral block guided by ultrasound) and paravertebral block by the thoracic surgeon at chest closure (paravertebral block visual). in people with Pain, run by CHU de Reims at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Post-thoracotomy pain is one of the most severe. The local analgesia allows its effective control and a reduction of postoperative morbidity and mortality. The gold standard for local analgesia is the thoracic epidural. However, this technique can be dangerous with severe complications. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Pain
What is being tested?
paravertebral block by the anesthetist before incision (paravertebral block guided by ultrasound) and paravertebral block by the thoracic surgeon at chest closure (paravertebral block visual).
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteFrance
Study dates
16 Aug 2016to 1 Sep 2021
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • patient with thoracotomy indication for segmentectomy (s), lobectomy (s) lung or pulmonary wedge resection
  • patient consenting to participate to the study
  • patient enrolled in the national healthcare insurance program
  • patient older than 18 years

Who cannot join

  • patient with neuropathy
  • patient with body mass index superior to 35 kg/m2
  • patient with contraindication for paravertebral block or local analgesia

Trial locations and contacts

1 site in 1 country.

France1 site
  • Chu de Reims

    Reims, 51092

Other trials in France

About this study

Official title: Comparison of the Clinical Efficacy of 2 Paravertebral Block Strategies in Thoracic Surgery by Thoracotomy: : by the Anesthetist (Paravertebral Block Guided by Ultrasound) and by the Thoracic Surgeon (Paravertebral Block Visual)

Post-thoracotomy pain is one of the most severe. The local analgesia allows its effective control and a reduction of postoperative morbidity and mortality.

The gold standard for local analgesia is the thoracic epidural. However, this technique can be dangerous with severe complications.

The paravertebral block showed comparable efficacy to the thoracic epidural for local analgesia . In addition, it has a better safety profile. There are several installation techniques. The difference in efficiency of these laying techniques is unknown.

Read the detailed description

Compare the clinical effectiveness of two strategies of realization of paravertebral block: by the anesthetist before incision (paravertebral block guided by ultrasound) and by the thoracic surgeon at chest closure (paravertebral block visual).

Conditions
Pain
Being tested
paravertebral block by the anesthetist before incision (paravertebral block guided by ultrasound), paravertebral block by the thoracic surgeon at chest closure (paravertebral block visual).
Keywords
thoracic surgery, thoracotomy
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • paravertebral block by the anesthetist before incision (paravertebral block guided by ultrasound)Other

  • paravertebral block by the thoracic surgeon at chest closure (paravertebral block visual).Other

Study groups in NCT02865226
Study groupRoleWhat they receive
experimental groupExperimentalparavertebral block by the anesthetist before incision (paravertebral block guided by ultrasound)
Receives: Other: paravertebral block by the anesthetist before incision (paravertebral block guided by ultrasound)
control groupActive comparatorparavertebral block by the thoracic surgeon at chest closure (paravertebral block visual)
Receives: Other: paravertebral block by the thoracic surgeon at chest closure (paravertebral block visual).

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pain

    Pain evaluated using a visual analog pain scale

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Aug 2016 (estimated)
  2. Study start16 Aug 2016
  3. Primary completion10 Oct 2020
  4. Study completion1 Sep 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02865226
Sponsor's protocol ID
PA15082
Acronym
PVBS-USguided
Status last verified
Feb 2025
First submitted
9 Aug 2016
Last updated
18 Feb 2025
Results posted
No

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing paravertebral block by the anesthetist before incision (paravertebral block guided by ultrasound) and paravertebral block by the thoracic surgeon at chest closure (paravertebral block visual). in people with Pain, run by CHU de Reims at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pain (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in